In line with our findings, decreased expression of DPT has been demonstrated in oral squamous cell carcinoma, hepatocellular carcinoma and related cell lines, breast and ovarian cancers, as well as uterine leiomyomas (14-19). Here, DPT is linked to uterine corpus leiomyoma.